Carboplatin + Paclitaxel
Used For:
| Primary treatment of advanced ovarian cancer. |
- Lung Cancer (Adenocarcinoma of the Lung)
- Lung Cancer (Large Cell Carcinoma of the Lung)
- Lung Cancer (Squamous Cell Carcinoma of the Lung)
Overview:
| This regimen combines two chemotherapy agents, carboplatin and paclitaxel. These two antineoplastic agents work in different ways to kill cancer cells. Carboplatin is a platinum-based compound, which interferes with DNA structure and inhibits production of DNA. This leads to prevention of cell division and eventual cell death. Paclitaxel is an antimetabolite agent known as a taxane. Taxanes interfere with the formation of microtubules, structures in the cell that are vital for cell division. Paclitaxel causes the formation of dysfunctional microtubules that cannot be dismantled by the cell. Unable to divide, the cell is stranded mid-cycle and dies. The combination of the two agents aims to kill more cancer cells than one agent alone because of the different mechanisms of action. |
Constituents:
Sign up for free newsletters
Discuss on Forum
Share on Twitter
Share on Facebook
Share on StumbleUpon
Print this article
Bookmark this page (press Ctrl+D)Article Dates:
| Created: 12/5/2006 | Modified: 29/5/2008 |
 |  |
Current Sponsors
Proudly brought to you by
Proudly brought to you by
Accreditation and Awards
Accreditations and Awards
|
|
|
|
|
|
 |
|
Current Sponsors
|
Australia’s leading source for trustworthy medical information written by health professionals. Please be aware that we do not give advice on your individual medical condition, Information on this site must be discussed with your treating doctor. Virtual Medical Centre © 2002 - 2010 | Privacy Policy Last updated 3 Sep 2010 |
 RSS News feed
|
|
|
For Banner Advertising |
Website and videos by |
|
| ^ Back to Top | ||
